Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
Respir Med Case Rep
; 34: 101563, 2021.
Article
in English
| MEDLINE | ID: covidwho-1556049
ABSTRACT
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one month later. However, he soon developed purpura in his lower limbs and thrombocytopenia, and immune thrombocytopenia was subsequently diagnosed. Although immune thrombocytopenia is one of the early complications of COVID-19, the use of corticosteroids for COVID-19 is thought to be a factor in the late onset of immune thrombocytopenia. In cases of severe COVID-19 for which corticosteroids were used for treatment, autoimmune diseases such as immune thrombocytopenia may manifest themselves late in the disease course.
COVID, coronavirus disease 2019; COVID-19; DAH, diffuse alveolar hemorrhage; Diffuse alveolar hemorrhage; HD, hospital day; HFNC, high-flow nasal cannula; IVIG, intravenous immunoglobulin; Immune thrombocytopenia; Purpura; RT-PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
Respir Med Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
J.rmcr.2021.101563
Similar
MEDLINE
...
LILACS
LIS